Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY - FinancialContent

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Inks Avexitide Supply Deals With Bachem and Polypeptide; $30 Million Upfront to Reserve Capacity - TradingView

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

ScieGen Pharmaceuticals Inc. plans 60,000-square-foot plant in Hauppauge - Newsday

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

N.J. pharmaceutical giant trims another 54 jobs as massive $3B cost-cutting effort in Union County rolls on - Yahoo Finance

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Jazz Pharma (NASDAQ: JAZZ) exec plans $486K Rule 144 stock sale - Stock Titan

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Zenas BioPharma (ZBIO), Why Is It Getting Attention Now? - simplywall.st

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

60 Degrees Pharma flags going-concern risk - Stock Titan

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff - MarketWatch

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Mirum Pharmaceuticals Names Dr. Rob Myers Chief Medical Officer - citybiz

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals gains analyst boost afte... - Pluang

news.google.com · 09 Sep 2026

Google News – Clinical Trials External News

A cancer drug combination produced responses in 75% of patients at the 500 mg dose - Stock Titan

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA Recalls and Warnings: Erectile Dysfunction Drug Ingredients Recalled Over Serious Quality Control Concerns - MedShadow Foundation

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - The Motley Fool

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Jefferies raises Tarsus Pharmaceuticals price target on guidance - Investing.com

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits - The Motley Fool

news.google.com · 09 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY - FinancialContent

Amylyx Pharmaceuticals Inks Avexitide Supply Deals With Bachem and Polypeptide; $30 Million Upfront to Reserve Capacity - TradingView

ScieGen Pharmaceuticals Inc. plans 60,000-square-foot plant in Hauppauge - Newsday

N.J. pharmaceutical giant trims another 54 jobs as massive $3B cost-cutting effort in Union County rolls on - Yahoo Finance

Jazz Pharma (NASDAQ: JAZZ) exec plans $486K Rule 144 stock sale - Stock Titan

Zenas BioPharma (ZBIO), Why Is It Getting Attention Now? - simplywall.st

60 Degrees Pharma flags going-concern risk - Stock Titan

Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff - MarketWatch

Mirum Pharmaceuticals Names Dr. Rob Myers Chief Medical Officer - citybiz

Tarsus Pharmaceuticals gains analyst boost afte... - Pluang

A cancer drug combination produced responses in 75% of patients at the 500 mg dose - Stock Titan

FDA Recalls and Warnings: Erectile Dysfunction Drug Ingredients Recalled Over Serious Quality Control Concerns - MedShadow Foundation

Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - The Motley Fool

Jefferies raises Tarsus Pharmaceuticals price target on guidance - Investing.com

Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits - The Motley Fool